Global High‐Risk Escherichia coli Clones in Moroccan Aquatic Settings: Genomic Evidence of Environmental Dissemination Authors: Amine Aiddi, Ilham Zerdani, Aboubakr Khazaz, Hafsa Mguild, Adil El Hamouchi, Kaotar Nayme Published: 2026 ABSTRACT BackgroundGlobally disseminated high‐risk Escherichia coli (E. coli) clones are major drivers of multidrug resistance (MDR) and severe clinical infections. Their presence in aquatic ecosystems represents a growing One Health concern, particularly in regions where wastewater management remains limited.ObjectiveThis study aimed to investigate the environmental circulation and genomic characteristics of high‐risk E. coli in Moroccan aquatic environments.MethodsWater samples were collected between February and June 2024 from seven major rivers and three wastewater treatment plants (WWTPs) across eight Moroccan cities. A total of 22 E. coli isolates were recovered and analyzed by whole‐genome sequencing to determine their sequence types (STs), antimicrobial resistance genes, virulence factors, and plasmid replicon profiles.ResultsSixteen isolates originated from rivers (72.7%) and six from WWTPs (27.3%). Thirteen distinct STs were identified, dominated by the globally disseminated high‐risk clones ST44 (n = 4; 18.2%), ST410 (n = 4; 18.2%), and ST131 (n = 3; 13.6%). The most frequent extended‐spectrum β‐lactamase (ESBL) gene was bla CTX-M-15 (n = 13; 59.1%). Carbapenemase genes were found in five isolates (22.7%), including blaNDM-5 (n = 2; 9.1%), blaOXA-48 (n = 1; 4.5%), blaOXA-181 (n = 1; 4.5%), blaOXA-484 (n = 2; 9.1%), and blaOXA-244 (n = 1; 4.5%), whereas mcr-1.1 was detected in one isolate (4.5%). Plasmid profiling showed a predominance of IncF‐type replicons (IncFIB 81.8%, IncFII 77.3%, and IncFIA 68.2%), along with IncI (36.4%), IncX (13.6%), and IncHI (9.1%).ConclusionThis study provides the first genomic evidence of clinically relevant high‐risk E. coli clones and mobile resistance determinants circulating in Moroccan aquatic environments. These findings highlight the urgent need to strengthen integrated One Health surveillance to prevent environmental dissemination and reduce the public health impact of antimicrobial resistance. 1. Introduction Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges, undermining the effectiveness of antibiotics that are essential for treating bacterial infections [1]. In 2019, AMR was responsible for an estimated 1.27 million deaths worldwide, with the greatest impact observed in low‐ and middle‐income countries (LMICs) [2]. Among Gram‐negative bacteria, multidrug‐resistant (MDR) Enterobacterales have gained particular attention due to their ability to acquire and disseminate resistance determinants, including extended‐spectrum β‐lactamase (ESBL), ampicillinase C (AmpC), and carbapenemase genes [3]. This evolution has severely limited treatment options, forcing clinicians to rely on last‐resort antibiotics. Within this group, Escherichia coli (E.coli) occupies a central position as both a commensal organism and a major opportunistic pathogen responsible for extraintestinal infections, notably urinary tract, and bloodstream infections [4]. Its ubiquity across human, animal, and environmental niches facilitates the acquisition and dissemination of resistance genes, making it a valuable sentinel species for AMR surveillance [5]. Over the past two decades, the global spread of high‐risk E. coli clones, including ST131, ST410, ST648, and ST38, has accelerated the transmission of resistance, primarily through plasmid‐mediated β‐lactamase genes such as bla CTX-M, bla NDM, and bla OXA-48-like [6]. In Morocco, hospital‐based outbreaks involving E. coli strains producing NDM‐1, OXA‐48, and CTX‐M‐15 have been increasingly reported, in both clinical and community‐acquired infections [7], indicating that high‐risk lineages are already established in healthcare settings. Although AMR surveillance has largely focused on clinical contexts, emerging evidence highlights the environment, particularly aquatic systems, as a critical reservoir for antibiotic resistance genes (ARGs) [8]. Aquatic ecosystems receiving wastewater discharges from urban, industrial, and hospital sources serve as hotspots for the accumulation and dissemination of antibiotic‐resistant bacteria (ARB) [9]. These ecosystems harbor complex microbial communities where resistant bacteria, residual antibiotics, and mobile genetic elements (MGEs), such as plasmids and integrons, create ideal conditions for horizontal gene transfer (HGT) [10]. Several international studies have confirmed the presence of MDR E. coli in environmental waters, underlining the risk of AMR transmission through environmental exposure routes [11] [12]. However, data from LMICs, including Morocco, remain limited [13]. Inadequate wastewater treatment infrastructure, especially in urban centers, frequently leads to the release of untreated or poorly treated effluents into surface waters used for domestic, agricultural, or recreational purposes [14]. Moreover, the scarcity of molecular studies examining resistance mechanisms in environmental E. coli isolates hinders our understanding of their evolution, adaptation, and dissemination within aquatic ecosystems. To address this gap, the present study was conducted as part of a pilot investigation on environmental AMR in Morocco, focusing on the occurrence and genomic characteristics of E. coli isolated from wastewater and surface waters across several regions. Using whole‐genome sequencing (WGS), we characterized their resistome, virulome, plasmid content, and phylogenetic background to assess the potential migration of high‐risk E. coli clones from clinical settings into aquatic environments. These findings provide new insights into the role of Moroccan water ecosystems as secondary reservoirs contributing to the persistence and dissemination of clinically relevant E. coli lineages. 2. Material and Methods 2.1. Sample Sites and Collection A targeted water sampling campaign was conducted between February and June 2024 across eight Moroccan cities as part of a pilot study on environmental AMR surveillance. Sampling was performed monthly during the study period, with selected sites visited according to logistical accessibility and local environmental priorities. In total, 27 grab water samples were collected, 21 from seven rivers and six from three wastewater treatment plants (WWTPs) (Figure 1). This sampling approach aimed to assess spatial variability in bacterial contamination and resistance patterns across aquatic ecosystems exposed to varying levels of anthropogenic pressure. Map of Morocco showing the sampling sites. 2.1.1. River Sampling Seven major rivers were investigated: Oued sebou (Kenitra), Oued bouregreg (Rabat), Oued cherrat (Skhirat), Oued nfifikh (Mohammedia), Oued merzeg (Casablanca), Oued tensift (Marrakech), and Oued souss (Agadir), selected to represent diverse hydrological conditions and varying degrees of anthropogenic influence, including domestic, agricultural, and industrial discharges. To assess spatial differences in contamination, discrete grab samples were collected from three sites along each river (upstream, midstream, and downstream), reflecting gradients in pollutant exposure and potential bacterial dissemination. At each site, 500 mL of surface water was sampled at approximately 30‐cm depth using sterile glass containers. 2.1.2. Wastewater Sampling Three WWTPs located in Marrakech, Agadir, and Mediouna were included in this study. At each plant, grab samples were collected from both the untreated influent and the treated effluent to assess treatment efficiency and to characterize the potential persistence or release of resistant bacteria into receiving waters. This approach ensured the inclusion of key exposure points while enabling a comparative analysis of resistance profiles before and after treatment. Wastewater samples were collected using sterile 500‐mL polypropylene bottles. To maintain integrity, all samples were stored at 4°C, transported to the laboratory in a covered icebox, and processed within 6 h of collection. Sampling procedures followed international standards, including ISO 19458:2006 and the Standard Methods for the Examination of Water and Wastewater [15, 16]. 2.2. Bacterial Isolation and Identification Water samples were processed for microbiological analysis using a selective enrichment approach. A 500‐μL aliquot from each sample was inoculated into brain heart infusion (BHI) broth (Bio‐Rad) and incubated at 37°C for 24 h to promote bacterial growth. After incubation, 10 μL of the enriched broth was streaked onto Brilliance UTI Clarity Agar (Oxoid), a chromogenic medium supplemented with ertapenem (0.5 μg/mL) or ceftazidime (3 μg/mL) for the selective isolation of carbapenem‐resistant and ESBL‐producing E. coli, respectively. Plates were incubated aerobically at 37°C for 18–24 h. The restreaking procedure was repeated until pure colonies were obtained. Colony morphology was evaluated according to the manufacturer′s recommendations, with E. coli typically producing dark pink to reddish colonies. Presumptive E. coli isolates were confirmed using the VITEK 2 system (bioMérieux, Marcy‐l′Étoile, France) and stored at −80°C for further analyses. 2.3. Antimicrobial Susceptibility Testing The antimicrobial susceptibility profiles of all confirmed isolates were assessed using the standard disc diffusion method on Mueller–Hinton agar (Bio‐Rad), following the recommendations of the Antibiogram Committee of the French Society for Microbiology (CA‐SFM) (https://www.sfm-microbiologie.org/). The following antibiotics discs were used: ampicillin (10 μg), amoxicillin–clavulanic acid (20/10 μg), ticarcillin (75 μg), cefoxitin (30 μg), ceftazidime (10 μg), cefotaxime (5 μg), cefepime (30 μg), aztreonam (30 μg), ertapenem (10 μg), imipenem (10 μg), ciprofloxacin (5 μg), ofloxacin (5 μg), amikacin (30 μg), gentamicin (10 μg), tobramycin (10 μg), and trimethoprim–sulfamethoxazole (1.25/23.75 μg) (Oxoid Ltd., Hampshire, United Kingdom). Susceptibility to colistin was determined using the broth microdilution method, according to CA‐SFM recommendations (https://www.sfm-microbiologie.org/). The Double Disc Synergy Test (DDST) was performed to confirm ESBL production. Quality control was performed using the standard reference strain E. coli (ATCC 25922). Isolates exhibiting resistance to three or more antimicrobial classes were classified as MDR according to standardized criteria [17]. Isolates displaying reduced susceptibility to at least one carbapenem were tested using the NG‐Test CARBA 5 (NG Biotech, France). This immunochromatographic assay detects KPC, NDM, VIM, IMP, and OXA‐48‐like enzymes, following the manufacturer′s instructions [18]. 2.4. DNA Extraction and WGS Genomic DNA was extracted from overnight cultures of E. coli grown in Luria–Bertani (LB) broth (Bio‐Rad) at 37°C using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer′s procedure. DNA concentration was measured using the Qubit 2.0 fluorometer (Thermo Fisher Scientific, USA), and purity was assessed with the ScanDrop2 spectrophotometer (Analytik Jena, Germany). WGS was carried out on 22 E. coli strains at the Genomic Sequencing Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco. Library preparation was performed using the Illumina DNA Prep Kit (Illumina, Eindhoven, Netherlands), and sequencing was conducted on the NextSeq 2000 platform (Illumina, San Diego, California, United States) using paired‐end reads (2 × 150 bp), targeting an average coverage depth of approximately 100×. 2.5. Bioinformatic Analysis 2.5.1. Quality Control and Genome Assembly The quality of generated paired‐end fastq reads was initially checked using FastQC (v0.12) (https://github.com/s-andrews/FastQC) and trimmed using trimmomatic (v0.39) (https://github.com/usadellab/Trimmomatic). High‐quality reads were then de novo assembled using SPAdes (v4.2.0) (https://github.com/ablab/spades). Assembly quality was evaluated with QUAST (v5.3.0) (https://github.com/ablab/quast), and contigs shorter than 500 bp were filtered out using BBMap (v39.01) (https://github.com/BioInfoTools/BBMap). The completeness and contamination of the final assemblies were assessed with CheckM (v1.2.2) (https://github.com/Ecogenomics/CheckM). Descriptive genome assembly statistics, including genome size, GC content, plasmid content, genome completeness, and contamination levels for all sequenced isolates, are provided in Table S1. 2.5.2. Genomic Characterization and Phylogenetic Analysis Species identification, MLST, serotype prediction, and detection of antimicrobial resistance genes were performed using Kleborate (v3.0.1) (https://github.com/klebgenomics/Kleborate). Virulence factors were screened using ABRicate (v1.0.1) (https://github.com/tseemann/abricate) against the Virulence Factor Database (VFDB). PlasmidFinder (v2.1) (https://cge.food.dtu.dk/services/PlasmidFinder/) was applied to identify plasmid replicon types, whereas MOB‐suite (v3.1.9) (https://github.com/phac-nml/mob-suite) was used to characterize plasmid structures and assess the association of resistance genes with plasmid sequences. Genome annotation was conducted through the Bacterial and Viral Bioinformatics Resource Center (BV‐BRC) (https://www.bv-brc.org). A whole‐genome comparison of assemblies was performed using the alignment‐free mode of Split K‐mer Analysis (SKA2) (v0.5.0) (https://github.com/bacpop/ska.rust), which detects core‐genome single‐nucleotide polymorphisms (SNPs) based on k‐mer variation with accuracy comparable to alignment‐based approaches. The resulting SNP alignment was used to infer a maximum‐likelihood phylogeny in RAxML (v8.2.12) (https://github.com/stamatak/standard-RAxML) under the GTR + GAMMA substitution model with 1000 bootstrap replicates to estimate branch support. 2.5.3. Data Visualization The final phylogenetic tree was visualized using the iTOL platform v7 (https://itol.embl.de/). A comparative analysis of the genetic context of carbapenemase and mcr1 encoding plasmids from EC90, EC114, EC121, and EC100 was carried out using BLAST Ring Image Generator (BRIG) v0.95 [19], aligning the reconstructed plasmid sequences with reference plasmids (GenBank accessions: MK291500.1, CP026476.1, CP045282.1, and KY471314.1). 3. Results 3.1. Bacterial Isolates and Antimicrobial Susceptibility Testing A total of 22 E. coli isolates exhibiting resistance to extended‐spectrum cephalosporins and/or carbapenems were recovered from Moroccan aquatic environments, including river water (16/22, 72.7%) and WWTPs (6/22, 27.3%). Among the WWTPs isolates, four originated from untreated wastewater (4/6, 66.7%) and two from treated effluents (2/6, 33.3%) (Table 1). All isolates exhibited resistance to penicillins and third‐generation cephalosporins (22/22, 100%), including ampicillin, amoxicillin–clavulanic acid, ticarcillin, cefotaxime, and ceftazidime. Resistance to aztreonam and cefepime was also frequent, detected in 18/22 isolates (81.8%) and 19/22 isolates (86.4%), respectively, whereas cefoxitin resistance was observed in 9/22 isolates (40.9%). Table 1Antimicrobial resistance phenotypes and colistin MIC distribution among environmental E. coli isolates from Moroccan aquatic settings.StrainCitySampling sitePhenotypic pattern of resistanceMIC of colistin (mg/L)EC8AgadirOued soussAMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP0.25EC45MohammediaOued nfifikhAMP, AMC, TIC, FOX, CTX, CAZ, FEP, ATM, ETP, OFX, CIP, TOB, GN, SXT0.25EC55CasablancaOued merzegAMP, AMC, TIC, CTX, CAZ, FEP, ATM, TOB, AK, SXT0.25EC61MohammediaOued nfifikhAMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, AK, GN, SXT0.25EC80MediounaWWTP mediouna (treated wastewater)AMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, SXT0.25EC90RabatOued bouregregAMP, AMC, TIC, FOX, CTX, CAZ, FEP, ETP, IMP, OFX, CIP, SXT0.25EC91RabatOued bouregregAMP, AMC, TIC, FOX, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, AK, SXT0.25EC96SkhiratOued cherratAMP, AMC, TIC, FOX, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, AK, SXT0.25EC97SkhiratOued cherratAMP, AMC, TIC, FOX, CTX, CAZ, FEP, ATM, OFX, CIP, SXT0.25EC99AgadirWWTP agadir (untreated wastewater)AMP, AMC, TIC, FOX, CTX, CAZ, OFX, CIP, SXT0.25EC100AgadirWWTP agadir (untreated wastewater)AMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, AK, GN, SXT, TOB, GN, SXT, COL4EC106AgadirWWTP agadir (treated wastewater)AMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, SXT0.25EC113AgadirOued soussAMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, SXT0.25EC114AgadirWWTP agadir (untreated wastewater)AMP, AMC, TIC, FOX, CTX, CAZ, FEP, ATM, ETP, IMP, TOB, GN, SXT0.25EC116AgadirOued soussAMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, SXT0.25EC119KenitraOued sebouAMP, AMC, TIC, CTX, CAZ, FEP, ATM, OFX, CIP, TOB, GN, SXT0.25EC120KenitraOued sebouAMP, AMC, TIC, CTX, CAZ, FEP, ATM, ETP, TOB, GN, SXT0.25EC121MarrakechWWTP marrakech (treated wastewater)AMP, AMC, TIC, CTX, CAZ, FEP, ETP, TOB, GN, SXT0.25EC128MarrakechOued tensiftAMP, AMC, TIC, FOX, CTX, CAZ, ATM, OFX, CIP, TOB, GN0.25EC135CasablancaOued merzegAMP, AMC, TIC, FOX, CTX, CAZ, ATM, ETP, OFX, CIP, TOB, GN, SXT0.25EC141CasablancaOued merzegAMP, AMC, TIC, FOX, CTX, CAZ, ATM, ETP, OFX, CIP, TOB, GN, SXT0.25EC146CasablancaOued merzegAMP, AMC, TIC, CTX, CAZ, ATM, OFX, CIP, TOB, GN, SXT0.25Abbreviations: AK, amikacin; AMC, amoxicillin–clavulanic acid; AMP, ampicillin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; COL, colistin; CTX, cefotaxime; ETP, ertapenem; FEP, cefepime; FOX, cefoxitin; GN, gentamicin; IMP, imipenem; OFX, ofloxacin; SXT, trimethoprim–sulfamethoxazole; TIC, ticarcillin; TOB, tobramycin. Antimicrobial resistance phenotypes and colistin MIC distribution among environmental E. coli isolates from Moroccan aquatic settings. Abbreviations: AK, amikacin; AMC, amoxicillin–clavulanic acid; AMP, ampicillin; ATM, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; COL, colistin; CTX, cefotaxime; ETP, ertapenem; FEP, cefepime; FOX, cefoxitin; GN, gentamicin; IMP, imipenem; OFX, ofloxacin; SXT, trimethoprim–sulfamethoxazole; TIC, ticarcillin; TOB, tobramycin. Resistance to fluoroquinolones was widespread, with 20 out of 22 isolates (90.9%) exhibiting reduced susceptibility to ofloxacin and ciprofloxacin. Aminoglycoside resistance was also frequent, notably against tobramycin and gentamicin (18/22, 81.8%). Nearly all isolates were resistant to trimethoprim–sulfamethoxazole (19/22, 86.4%), whereas reduced susceptibility to carbapenems (ertapenem or imipenem) was observed in 4/22 isolates (18.2%). Only one isolate EC100 exhibited a colistin MIC of 4 mg/L, indicating phenotypic resistance. The detailed antimicrobial susceptibility profiles are presented in Table 1. 3.2. MLST and Phylogenetic Analysis MLST analysis identified 13 distinct sequence types (STs) among the 22 E. coli isolates. The most frequent lineages were ST44 (n = 4) and ST410 (n = 4), followed by ST131 (n = 3) and ST156 (n = 2). The remaining isolates were assigned to single STs, including ST10, ST38, ST90, ST155, ST1598, ST224, ST617, ST648, and ST3268 (Figure 2). Phylogenetic tree of environmental E. coli isolates from Moroccan aquatic settings and their genomic features. Core genome SNP‐based phylogenetic reconstruction performed using SKA2 and RAxML revealed distinct clustering patterns consistent with MLST assignments. Cluster I (ST44) included four isolates (EC45, EC97, EC131, and EC141) and showed minimal intralineage variation, with the closest pair (EC116–EC119) differing by 56 SNPs. Cluster II (ST410) comprised four isolates (EC90, EC106, EC120, and EC135) and also exhibited low genomic divergence, with 158 SNPs between EC128 and EC135. Cluster III (ST131) contained three isolates (EC8, EC91, and EC113) with the smallest pairwise distance of 104 SNPs between EC8 and EC91. In contrast, isolates belonging to single‐occurrence STs were positioned on independent branches and displayed much larger SNP distances, reflecting higher genomic separation within the collection (Figure 2). 3.3. Resistome Profile Whole‐genome analysis revealed a diverse resistome encompassing multiple antibiotic classes (Table 2). β‐lactam resistance genes were the most prevalent, with blaCTX-M-15 (n = 13; 59.1%) as the dominant variant, followed by blaOXA-1 (n = 11; 50.0%). Additional ESBL and AmpC genes were identified, including blaCMY-42 (n = 3; 13.6%) and blaDHA-1 (n = 2; 9.1%), as well as single detections of blaCMY-2 , blaLAP-2 , blaADC-75 , blaSHV-12 , blaCTX-M-55 , and blaCTX-M-276 (each n = 1; 4.5%). Carbapenemase genes were also detected, notably blaNDM-5 (n = 2; 9.1%), blaOXA-48 (n = 1; 4.5%), blaOXA-181 (n = 1; 4.5%), blaOXA-484 (n = 2; 9.1%), and blaOXA-244 (n = 1; 4.5%). Table 2Antibiotic resistance genes and plasmids replicons found in environmental E. coli isolates.StrainSTAminoglycosides β‐lactamsFluoroquinolonesSulfonamidesTrimethoprimTetracyclinesPhenicolsMacrolidesColistinPlasmidsEC10010 aadA1; aadA2; aac(6 ′ )-Ibcr5 blaCTX-M276; blaOXA-1; blaTEM-1 parC_S80I; parE_S458A; gyrA_D87N; gyrA_S83L; aac(6 ′ )-Ib-cr5 sul3 — — cmlA1; catB3 — mcr-1.1 IncFIA; IncFIB(AP001918); IncFIC(FII); IncIEC45617 aadA5; aac(3)-IId; aac(6 ′ )-Ib-cr5 blaTEM-1; blaOXA-1 gyrA_D87N; gyrA_S83L; parE_S458A; parC_S80I; aac(6 ′ )-Ib-cr5 sul1 dfrA17 tet(B) catA1; catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFIIEC10644 aph(3 ″ )-Ib; aph(6)-Id; aac(6 ′ )-Ib-cr5; aadA5 blaDHA-1; blaCTX-M-15; blaOXA-1; blaTEM-1 qnrB4; qnrS1; gyrA_D87N; gyrA_S83L; aac(6 ′ )-Ib-cr5 sul1 dfrA17; dfrA7 tet(A); tet(B) floR; catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncX1; IncX4; IncYEC11644 aadA5; aac(6 ′ )-Ib-cr5 blaCTX-M-15; blaOXA-1 gyrA_D87N; gyrA_S83L; parE_S458T; parC_S80I; aac(6 ′ )-Ib-cr5 sul1 — tet(B) catB3 mph(A) —IncFIA; IncFIB(AP001918; IncFII; IncIEC9644 aadA5; aac(6 ′ )-Ib-cr5 blaCTX-M-15; blaOXA-1 gyrA_D87N; gyrA_S83L; parE_S458T; parC_S80I; aac(6 ′ )-Ib-cr5 — dfrA17 tet(B) catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncX4EC11944 aadA5; aac(6 ′ )-Ib-cr5 blaCTX-M-15; blaOXA-1 gyrA_D87N; gyrA_S83L; parE_S458T; parC_S80I; aac(6 ′ )-Ib-cr5 sul1 dfrA17 tet(B) catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncIEC1211598 aadA5; aph(6)-Id; aph(3 ″ )-Ib blaCTX-M-15; blaTEM-1; blaOXA-48 gyrA_S83L sul1; sul2 dfrA17 tet(A) — mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncREC12038 aph(3 ″ )-Ib; aph(6)-Id blaTEM-1; blaOXA-244 — sul2 — — — — —IncFIA; IncFIB(AP001918); IncFIC(FII)EC553268 aadA1 blaCTX-M-15; blaTEM-1 qnrS1; qnrB1 — dfrA14 — catA1 — —IncFIB(AP001918); IncFIC(FII); IncFII; IncI; IncHI2EC61648 aph(6)Id; aph(3 ″ )Ib; aac(6 ′ )-Ib-cr5; aadA5; aadA1 blaLAP-2; blaCTX-M-15; blaOXA-1 gyrA_D87N; gyrA_S83L; parE_S458A; parC_S80I; aac(6 ′ )-Ib-cr5; qnrS sul1; sul2 dfrA17; dfrA1 tet(A) floR; catB3 mph(B); mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncHI2; IncHI2AEC8131 — blaCTX-M-15 parC_E84V; parC_S80I; parE_I529L; gyrA_D87N; gyrA_S83L — — — — mph(A) —IncFIB(pB171); IncFIIEC91131 aadA5; aph(6)-Id; aph(3 ″ )Ib; aac(6 ′ )-Ib-cr5 blaCTX-M-15; blaOXA-1; gyrA_D87N; gyrA_S83L; parC_E84V; parC_S80I; parE_I529L; aac(6 ′ )-Ib-cr5 sul1; sul2 — tet(A) catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFIIEC146131 aph(6)Id; aph(3 ″ )Ib; aac(6 ′ )-Ib-cr5; aac(3)-IId blaCTX-M-15; blaOXA-1; blaTEM-1 gyrA_D87N; gyrA_S83L; parE_I529L; parC_E84V; parC_S80I; aac(6 ′ )-Ib-cr5 sul1; sul2 — tet(A) — mph(A) —IncFIB(AP001918); IncFIIEC80224 aadA5; aph(6)-Id; aph(3 ″ )-Ib blaCTX-M-55 gyrA_D87N; gyrA_S83L; parC_S80I sul2 dfrA17 tet(A) floR — —IncH1BEC97155 — blaTEM-1; blaSHV-12 gyrA_S83L; qnrS1; qnrB19 sul2 dfrA14 tet(A) — — —IncFIB(AP00198; IncFII; IncI; IncP1EC90156 aadA2 blaTEM-1; blaOXA-181; blaNDM-5 parC_E84G; parC_S80I; gyrA_D87N; gyrA_S83L; qnrS1; qepA9 sul1 dfrA12 tet(B) — mph(A) —IncFIB(pB171); IncFII; IncX3EC113156 aph(6)-Id; aph(3 ″ )-Ib blaCTX-M-15; blaTEM-1 gyrA_D87N; gyrA_S83L; parE_L416F; parC_E84K; qnrB19 sul2; sul1 — tet(A); tet(B) floR — ——EC9990 — blaDHA-1 gyrA_D87N; gyrA_S83L; parC_S80I; parE_S458A; qnrB4 sul1 dfrA7 tet(A) — mph(A) —IncYEC114410 aac(6 ′ )-Ib-cr5; aadA2; aadA5; aph(6)Id; aph(3 ″ )Ib; aac(3)-IId blaOXA-1; blaCMY-2; blaCTX-M-15; blaTEM1; ompC_R195L; blaNDM-5 aac(6 ′ )-Ib-cr5; gyrA_D87N; gyrA_S83L; parC_S80I; parE_S458A; oqxA; qnrB sul1; sul2 dfrA12; dfrA17 tet(B) catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncH1B; IncR; IncQ1EC128410 aac(6 ′ )-Ib-cr5 blaCMY-42; blaCTX-M-15; blaOXA-1 parC_S80I; parE_S458A; gyrA_D87N; gyrA_S83L; aac(6 ′ )-Ib-cr5 — — tet(A) catB3 mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncI; IncYEC141410 ant(3 ″ )IIa; ant(2 ″ )Ia; aac(3)-IId; aph(3 ″ )Ib; aph(6)-Id; aadA5; aph(3 ′ )Ia; aph(3 ′ )-VIa blaCMY-42; blaADC-75; blaOXA-484 parE_S458A; parC_S80I; gyrA_D87N; gyrA_S83L; qnrS1 sul2; sul1 dfrA17 tet(B) — mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncI; IncX1; IncP1EC135410 aac(3)IId; aph(3 ″ )Ib; aph(6)-Id; aadA5 blaCMY-42; blaOXA-484 parE_S458A; parC_S80I; gyrA_D87N; gyrA_S83L; qnrS1 sul2; sul1 dfrA17 tet(B) — mph(A) —IncFIA; IncFIB(AP001918); IncFII; IncI; IncX1; IncP1 Antibiotic resistance genes and plasmids replicons found in environmental E. coli isolates. Aminoglycoside‐modifying enzyme genes were widespread, particularly aadA5 (n = 12; 54.5%), aac(6-Ib-cr5 (n = 11; 50.0%), aph(3 ″ )-Ib (n = 11; 50.0%), and aph(6)-Id (n = 11; 50.0%), with additional variants including aac(3)-IId (n = 5; 22.7%), aadA1 (n = 3; 13.6%), aadA2 (n = 3; 13.6%), ant(2 ″ )-Ia (n = 1; 4.5%), ant(3 ″ )-IIa (n = 1; 4.5%), aph(3 ′ )-Ia (n = 1; 4.5%), and aph(3 ′ )-VIa (n = 1; 4.5%). Fluoroquinolone resistance was mediated by both plasmid‐borne and chromosomal determinants. Plasmid‐mediated qnr genes were observed in 13 isolates (59.1%), including qnrS1 (n = 7; 31.8%), qnrB1 (n = 2; 9.1%), qnrB19 (n = 2; 9.1%), and qnrB4 (n = 2; 9.1%). Mutations in the quinolone resistance–determining regions (QRDR) were highly prevalent, specifically gyrA_S83L (n = 19; 86.4%) and parC_S80I (n = 16; 72.7%). Additional resistance determinants included sul1 (n = 14; 63.6%) and sul2 (n = 11; 50.0%) for sulfonamides; dfrA17 (n = 11; 50.0%) for trimethoprim; catB3 (n = 10; 45.5%), floR (n = 4; 18.2%), and catA1 (n = 2; 9.1%) for phenicols; mph(A) (n = 16; 72.7%) for macrolides; and tet(A) and tet(B) (each n = 11; 50.0%) for tetracyclines. Colistin resistance was detected in one isolate EC100 carrying mcr-1.1 (n = 1; 4.5%). 3.4. Plasmids Replicons Plasmid replicon typing revealed a diverse plasmid repertoire among the 22 E. coli isolates (Table 2). IncF‐type plasmids were the most prevalent, including IncFIB (AP001918) (n = 18; 81.8%), IncFII (n = 17; 77.3%), IncFIA (n = 15; 68.2%), and IncFIC (FII) (n = 3; 13.6%). These replicons frequently co‐occurred within the same isolates, indicating multireplicon IncF backbones. Secondary plasmid groups included IncI (n = 8; 36.4%), IncX‐type plasmids: IncX1 (n = 2; 9.1%), IncX3 (n = 3; 13.6%), and IncX4 (n = 2; 9.1%), as well as IncHI1B (n = 2; 9.1%). Additional incompatibility groups were found at lower frequencies, including IncQ1 (n = 4; 18.2%), IncY (n = 4; 18.2%), IncHI2 (n = 2; 9.1%), IncR (n = 2; 9.1%), IncP1 (n = 1; 4.5%), and IncHI2A (n = 1; 4.5%). Carbapenemase‐encoding genes were detected on distinct plasmid replicons among the three carbapenem‐resistant E. coli isolates (Table 2). The blaOXA-48 gene in EC121 was located on an IncFII‐type plasmid, whereas blaNDM-5 detected in EC90 and EC114 was associated with IncFIB‐type plasmids. In addition, EC90 carried an IncX3 plasmid coharboring blaOXA-181 and qnrS1, illustrating the diversity of plasmid backbones involved in the mobilization of carbapenemase genes. The colistin resistance gene mcr-1.1 was identified on an IncI2 plasmid (n = 1; 4.5%), detected in EC100. Overall, the plasmid content of these isolates highlighted a wide distribution of incompatibility groups, encompassing conjugative and mobilizable elements associated with key resistance determinants. 3.5. Virulence Factors and Serotyping A total of 56 virulence associated genes were identified in the analyzed isolates (Figure 3). The detected genes were grouped into six functional categories, comprising adhesion and fimbriae, iron acquisition and siderophores, invasion and secretion, immune evasion, biofilm or surface structures, and regulatory or efflux‐associated determinants. Distribution of virulence genes and serotypes among environmental E. coli isolates from Moroccan aquatic settings. Adhesion and fimbrial genes were widely distributed, including papA, papC, papF, papG-II, lpfA, fdeC, afaC, f17A, f17G, nfaE, and iha. These were detected in nearly all isolates, with extended fimbrial clusters observed in EC91, EC114, and EC146. Iron uptake and siderophore‐related genes (ybtP, ybtQ, iroB–E, iroN, iucA–D, and iutA) were also common, particularly abundant in EC61, EC90, EC96, EC100, and EC106. Invasion and secretion genes (eilA and espX1) were consistently identified across the collection. Genes associated with immune evasion and serum resistance (iss and cvaC) were identified in over two‐thirds of the isolates, whereas biofilm and surface‐associated elements (capU) appeared sporadically. Regulatory and efflux‐linked virulence genes (adeC, acrF, emrD, emrE, mdtM, amvA, abaF, air, ariR, and uhpT_E350Q) occurred in nearly all isolates, often co‐occurring with other functional categories. Serotyping identified 15 distinct O:H combinations among the isolates (Figure 3). The most recurrent serotypes were O25:H4 (n = 3), O8:H21 (n = 3), and H4 (n = 3), whereas others such as O8:H4, O9:H4, O86:H18, O153:H9, O1:H6, H10, H23, O37:H34, O54:H28, O100:H28, O8:H9, and H9 were detected in single isolates. 4. Discussion In this study, the genomic diversity observed among the 22 E. coli isolates recovered from Moroccan aquatic environments highlights the coexistence of multiple high‐risk lineages within rivers and wastewater systems. MLST analysis revealed 13 distinct STs, with ST44, ST410, and ST131 being the most frequent, followed by ST156 and several sporadic types including ST10, ST38, ST617, ST648, and ST1598. The predominance of globally disseminated lineages such as ST410 and ST131 suggests that environmental waters act as reservoirs reflecting the clones circulating in clinical settings. ST410 is an emerging high‐risk clone frequently carrying carbapenemases and ESBL genes isolated not only from humans but also from wastewater and surface water sources [20]. Similarly, ST131 represents one of the most successful extraintestinal pathogenic E. coli (ExPEC) lineages, responsible for a significant proportion of urinary tract and bloodstream infections worldwide [21]. In Morocco, E. coli ST131 producing blaCTX-M-15 was reported as the dominant clone among community and hospital‐associated urinary isolates [22], sharing identical resistance determinants with the environmental ST131 detected in this study. The presence of this lineage in both clinical and environmental contexts provides strong evidence of its continuous dissemination and persistence across human and aquatic compartments. Phylogenetic reconstruction confirmed the clustering of isolates within their respective STs, with limited SNP variation within major clades, supporting the hypothesis of recent common ancestry and local persistence of these clones across geographically distinct Moroccan aquatic sites. These findings are consistent with previous environmental studies showing close genomic relatedness between aquatic and clinical isolates [23], highlighting the role of aquatic settings as a critical interface in the circulation of MDR E. coli between human and environmental compartments. Among all detected resistance determinants, ESBL genes were predominant, notably bla CTX-M-15 (n = 13) and bla TEM-1 (n = 13), followed by bla OXA-1 (n = 11). The dominance of CTX‐M‐15 aligns with its widespread occurrence among Moroccan clinical E. coli isolates in both hospital and community settings [24]. Its detection in both river and WWTP samples suggests that human‐derived discharges are contributing to the aquatic dissemination of ESBL‐producing clones. In addition, carbapenemase genes, including bla NDM-5, bla OXA-48, bla OXA-181, bla OXA-244, and bla OXA-484, were found in five isolates, reflecting the dominance of OXA‐48‐like and NDM variants previously reported in Moroccan clinical Enterobacterales isolates [7]. Their detection in aquatic samples highlights the persistence of these clinically derived carbapenemase genes in the environment and their potential role in the broader dissemination of carbapenem resistance. Beyond β‐lactams resistance, the plasmid‐mediated mcr-1.1 gene detected in one isolate EC100 from a WWTP influent represents an alarming signal of emerging transferable colistin resistance within Moroccan aquatic environments. This finding extends the resistance spectrum observed in the present study and suggests that selective pressures in wastewater systems may favor the persistence of mobile elements conferring resistance to last‐resort antibiotics. Alongside this, several additional resistance genes such as aadA5, aac(6 ′ )-Ib-cr5, qnrS1, sul1, tet(A/B), and catB3, together with chromosomal mutations in gyrA and parC, were detected in isolates from both rivers and WWTPs, reflecting the accumulation of multiple resistance mechanisms within these environments. Plasmid replicon typing revealed diverse incompatibility groups among the E. coli isolates, dominated by IncF‐type backbones, IncFII, IncFIA, and IncFIB, which frequently coexisted within the same strains, indicating mosaic multireplicon structures typical of ESBL and carbapenemase producing E. coli (Figure 4). Carbapenemase genes were carried on distinct plasmids: blaOXA-48 in EC121 was located on an IncFII plasmid identical to pCP045282.1 first reported from a clinical E. coli isolate in Lebanon [25]. In EC90 and EC114, blaNDM-5 was associated with IncFIB plasmids highly similar to pMK291500.1 identified in E. coli from chicken meat in Pakistan [26]. EC90 also harbored blaOXA-181 and qnrS1 on an IncX3 plasmid closely related to pCP026476.1 originally described in a E. coli isolate from South Korea [27]. Furthermore, EC100, recovered from WWTP, carried mcr-1.1 on an IncI2 plasmid sharing > 99% identity with pKY471314, previously detected in a bloodstream E. coli isolate from Argentina [28]. Taken together, these comparisons reveal a striking genomic convergence between plasmids circulating in Moroccan aquatic environments and plasmids previously reported from geographically distant regions and diverse ecological sources. The near‐identical backbone structures observed across these plasmids strongly suggest that globally disseminated resistance plasmids are circulating across human, animal, and environmental compartments. Such findings support the concept that aquatic ecosystems function as environmental interfaces where internationally distributed antimicrobial resistance plasmids can persist, accumulate, and potentially facilitate the exchange of clinically relevant resistance determinants within a One Health context. BLAST ring comparison of plasmids carrying resistance genes from environmental E. coli isolates recovered in this study and their corresponding reference sequences. Each ring represents a reconstructed plasmid sequence aligned to the reference plasmid at the center. (A) EC121—IncFII plasmid aligned with pOXA48 (accession: CP045282.1, Lebanon). (B) EC90 and EC114—IncFIB plasmid aligned with pNDM5 (accession: MK291500.1, Pakistan). (C) EC90—IncX3 plasmid aligned with pOXA181 (accession: CP026476.1, South Korea). (D) EC100—IncI2 plasmid aligned with pMCR1 (accession: KY471314.1, Argentina). The characteristics of virulence genes showed that a large proportion of the environmental E. coli isolates carried adhesion‐ and fimbriae‐associated genes (papA, papC, papG-II, lpfA, fdeC, and afaC), which are crucial for colonization and infection of host tissues [29]. Iron acquisition genes (ybtP/Q; iroB, C, D, E, and N; iucA, B, C, and D; and iutA) were also highly prevalent, particularly among isolates recovered from wastewater, emphasizing their importance in bacterial persistence under nutrient‐limited conditions [30]. Immune evasion genes (iss and cvaC) and efflux‐related determinants (acrF, emrD, and mdtM) were frequently detected, supporting the adaptation of these isolates to environmental stress. Similar virulence repertoires have been described in Moroccan clinical E. coli isolates responsible for urinary tract infections [22], suggesting a shared genetic background between environmental and clinical populations. The detection of serotypes O25:H4 and H4, commonly linked to the high‐risk clone ST131 [31], indicates that river and wastewater‐derived E. coli may contribute to the environmental circulation of virulent lineages with potential clinical relevance. Several factors should be considered when interpreting these findings. This study was designed as a pilot genomic investigation and therefore included a limited number of environmental isolates, which limits broad population‐level conclusions regarding the distribution of clones, plasmids, and resistance determinants across Moroccan aquatic ecosystems. In addition, the limited geographic coverage may not fully capture the diversity of antimicrobial‐resistant E. coli circulating in aquatic environments across Morocco. Finally, genomic analyses were performed using short‐read sequencing technologies (Illumina), which enable reliable detection of resistance genes and plasmid replicons but may not fully resolve complex plasmid structures or the precise genetic contexts of MGEs. Future studies integrating long‐read sequencing technologies, such as Oxford Nanopore or PacBio, would facilitate more accurate plasmid reconstruction and localization of key resistance determinants. 5. Conclusion This study provides the first genomic investigation of E. coli lineages circulating in Moroccan aquatic environments. The detection of globally distributed high‐risk clones, along with key resistance genes including ESBL, carbapenemases, and other resistance genes, underscores the convergence of clinically significant determinants within environmental reservoirs. The recovery of these isolates from both river and WWTPs reflects the continuous influence of anthropogenic activities in maintaining and spreading AMR beyond healthcare settings, underscoring the urgent need to strengthen integrated One Health surveillance and improve wastewater management practices to curb the environmental dissemination of MDR bacteria. Author Contributions Amine Aiddi: conceptualization, writing – original draft, data curation, investigation, methodology, visualization, formal analysis. Ilham Zerdani: supervision, validation, writing – review and editing, project administration, methodology, resources. Aboubakr Khazaz: methodology. Hafsa Mguild: methodology. Adil El Hamouchi: methodology. Kaotar Nayme: supervision, validation, writing – review and editing, project administration, methodology, resources. Funding This work was supported by the Centre National pour la Recherche Scientifique et Technique, 10.13039/501100006319, 8 UH2C2023. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting Information Additional supporting information can be found online in the Supporting Information section. Table S1: Genome assembly and quality metrics of the 22 sequenced Escherichia coli isolates, including genome size, GC content, plasmid content, genome completeness, and estimated contamination levels.